WE PHARMA ANNOUNCES NAME CHANGE TO WEP CLINICAL
As of 25 November 2016, our company name will officially change from: WE Pharma to WEP Clinical We believe that our new name more accurately reflects the services that we now provide. Our new [...]
We are a Pharmaceutical Services Provider that specializes in Drug Development Programs, Treatment Access Solutions and Market Access and Commercialization
We are experienced in Phase I – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.
We are experienced in Phase I – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.
Industry leader with over 16 years of experience designing and deliveing calue-driven Expanded Access (EAPs) and Post-Trial Access Programs.
As of 25 November 2016, our company name will officially change from: WE Pharma to WEP Clinical We believe that our new name more accurately reflects the services that we now provide. Our new [...]